0000828146--12-31 2024 Q2 false 200000 200000 200000 9860000 9860000 9860000 9860368 6573570 P5Y3M19D 0000828146 ilink:ShareRepurchaseSharesSoldInDecember2022Member 2023-05-31 0000828146 ilink:ShareRepurchaseProgramMay2023Member 2023-05-31 0000828146 ilink:ShareRepurchaseSharesSoldInDecember2022Member 2023-05-01 2023-05-31 0000828146 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000828146 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0000828146 ilink:ShareRepurchaseProgramMay2023Member 2024-04-01 2024-06-30 0000828146 ilink:ShareRepurchaseProgramMay2023Member 2024-01-01 2024-06-30 0000828146 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000828146 ilink:ShareRepurchaseProgramMay2023Member 2023-04-01 2023-06-30 0000828146 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0000828146 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000828146 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0000828146 us-gaap:RetainedEarningsMember 2024-06-30 0000828146 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000828146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000828146 us-gaap:RetainedEarningsMember 2024-03-31 0000828146 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000828146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000828146 2024-03-31 0000828146 us-gaap:RetainedEarningsMember 2023-12-31 0000828146 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000828146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000828146 us-gaap:RetainedEarningsMember 2023-06-30 0000828146 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000828146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000828146 us-gaap:RetainedEarningsMember 2023-03-31 0000828146 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000828146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000828146 2023-03-31 0000828146 us-gaap:RetainedEarningsMember 2022-12-31 0000828146 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000828146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000828146 us-gaap:PreferredStockMember 2024-06-30 0000828146 us-gaap:CommonStockMember 2024-06-30 0000828146 us-gaap:PreferredStockMember 2024-03-31 0000828146 us-gaap:CommonStockMember 2024-03-31 0000828146 us-gaap:PreferredStockMember 2023-12-31 0000828146 us-gaap:CommonStockMember 2023-12-31 0000828146 us-gaap:PreferredStockMember 2023-06-30 0000828146 us-gaap:CommonStockMember 2023-06-30 0000828146 us-gaap:PreferredStockMember 2023-03-31 0000828146 us-gaap:CommonStockMember 2023-03-31 0000828146 us-gaap:PreferredStockMember 2022-12-31 0000828146 us-gaap:CommonStockMember 2022-12-31 0000828146 us-gaap:RestrictedStockUnitsRSUMember ilink:OmnibusIncentivePlan2019Member 2024-05-31 0000828146 ilink:EuropeAndOtherMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-04-01 2024-06-30 0000828146 ilink:AsiaAndMiddleEastMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-04-01 2024-06-30 0000828146 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-04-01 2024-06-30 0000828146 us-gaap:SalesRevenueNetMember 2024-04-01 2024-06-30 0000828146 ilink:EuropeAndOtherMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-06-30 0000828146 ilink:AsiaAndMiddleEastMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-06-30 0000828146 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-06-30 0000828146 us-gaap:SalesRevenueNetMember 2024-01-01 2024-06-30 0000828146 ilink:EuropeAndOtherMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-04-01 2023-06-30 0000828146 ilink:AsiaAndMiddleEastMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-04-01 2023-06-30 0000828146 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-04-01 2023-06-30 0000828146 us-gaap:SalesRevenueNetMember 2023-04-01 2023-06-30 0000828146 ilink:EuropeAndOtherMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-06-30 0000828146 ilink:AsiaAndMiddleEastMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-06-30 0000828146 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-06-30 0000828146 us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0000828146 us-gaap:LeaseholdImprovementsMember 2024-06-30 0000828146 ilink:FurnitureMachineryAndEquipmentMember 2024-06-30 0000828146 us-gaap:LeaseholdImprovementsMember 2023-12-31 0000828146 ilink:FurnitureMachineryAndEquipmentMember 2023-12-31 0000828146 ilink:SeriesConvertiblePreferredStockMember 2024-06-30 0000828146 ilink:SeriesConvertiblePreferredStockMember 2023-12-31 0000828146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000828146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0000828146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000828146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0000828146 us-gaap:OperatingExpenseMember 2024-04-01 2024-06-30 0000828146 us-gaap:CostOfSalesMember 2024-04-01 2024-06-30 0000828146 us-gaap:OperatingExpenseMember 2024-01-01 2024-06-30 0000828146 us-gaap:CostOfSalesMember 2024-01-01 2024-06-30 0000828146 us-gaap:OperatingExpenseMember 2023-04-01 2023-06-30 0000828146 us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0000828146 us-gaap:OperatingExpenseMember 2023-01-01 2023-06-30 0000828146 us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0000828146 srt:EuropeMember us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2024-06-30 0000828146 srt:AsiaMember us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2024-06-30 0000828146 country:US us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2024-06-30 0000828146 us-gaap:AssetsTotalMember 2024-06-30 0000828146 srt:EuropeMember us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2023-12-31 0000828146 srt:AsiaMember us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2023-12-31 0000828146 country:US us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2023-12-31 0000828146 us-gaap:AssetsTotalMember 2023-12-31 0000828146 ilink:QbakMember 2024-04-01 2024-06-30 0000828146 ilink:BkfCapitalMember 2024-04-01 2024-06-30 0000828146 ilink:QbakMember 2024-01-01 2024-06-30 0000828146 ilink:BkfCapitalMember 2024-01-01 2024-06-30 0000828146 ilink:QbakMember 2023-04-01 2023-06-30 0000828146 ilink:BkfCapitalMember 2023-04-01 2023-06-30 0000828146 ilink:QbakMember 2023-01-01 2023-06-30 0000828146 ilink:BkfCapitalMember 2023-01-01 2023-06-30 0000828146 us-gaap:OrderOrProductionBacklogMember 2024-06-30 0000828146 us-gaap:NoncompeteAgreementsMember 2024-06-30 0000828146 us-gaap:IntellectualPropertyMember 2024-06-30 0000828146 us-gaap:InProcessResearchAndDevelopmentMember 2024-06-30 0000828146 us-gaap:DevelopedTechnologyRightsMember 2024-06-30 0000828146 us-gaap:CustomerRelationshipsMember 2024-06-30 0000828146 us-gaap:OrderOrProductionBacklogMember 2023-12-31 0000828146 us-gaap:NoncompeteAgreementsMember 2023-12-31 0000828146 us-gaap:IntellectualPropertyMember 2023-12-31 0000828146 us-gaap:InProcessResearchAndDevelopmentMember 2023-12-31 0000828146 us-gaap:DevelopedTechnologyRightsMember 2023-12-31 0000828146 us-gaap:CustomerRelationshipsMember 2023-12-31 0000828146 us-gaap:RestrictedStockUnitsRSUMember ilink:OmnibusIncentivePlan2019Member 2024-06-30 0000828146 us-gaap:RestrictedStockUnitsRSUMember ilink:OmnibusIncentivePlan2019Member 2024-01-01 2024-06-30 0000828146 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000828146 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0000828146 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0000828146 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000828146 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0000828146 us-gaap:ForeignCountryMember 2024-06-30 0000828146 us-gaap:ForeignCountryMember 2023-12-31 0000828146 ilink:SeriesaConvertiblePreferredStockMember 2024-06-30 0000828146 ilink:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0000828146 ilink:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0000828146 ilink:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2024-01-01 2024-06-30 0000828146 ilink:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2024-01-01 2024-06-30 0000828146 ilink:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0000828146 ilink:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0000828146 ilink:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0000828146 ilink:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0000828146 ilink:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0000828146 ilink:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-12-31 0000828146 ilink:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-12-31 0000828146 ilink:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0000828146 2024-02-29 0000828146 2023-06-30 0000828146 2022-12-31 0000828146 ilink:CalmanTechnologyLimitedMember us-gaap:TrademarksAndTradeNamesMember 2023-03-17 0000828146 ilink:CalmanTechnologyLimitedMember us-gaap:NoncompeteAgreementsMember 2023-03-17 0000828146 ilink:CalmanTechnologyLimitedMember us-gaap:DevelopedTechnologyRightsMember 2023-03-17 0000828146 ilink:CalmanTechnologyLimitedMember us-gaap:CustomerRelationshipsMember 2023-03-17 0000828146 ilink:CalmanTechnologyLimitedMember 2024-04-01 2024-06-30 0000828146 ilink:CalmanTechnologyLimitedMember 2024-01-01 2024-06-30 0000828146 ilink:CalmanTechnologyLimitedMember 2023-04-01 2023-06-30 0000828146 ilink:CalmanTechnologyLimitedMember 2023-01-01 2023-06-30 0000828146 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-06-30 0000828146 ilink:SeriesaConvertiblePreferredStockMember 2024-04-01 2024-06-30 0000828146 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-06-30 0000828146 ilink:SeriesaConvertiblePreferredStockMember 2024-01-01 2024-06-30 0000828146 ilink:SeriesaConvertiblePreferredStockMember 2024-01-01 2024-06-30 0000828146 ilink:SeriesaConvertiblePreferredStockMember 2023-04-01 2023-06-30 0000828146 ilink:SeriesaConvertiblePreferredStockMember 2023-01-01 2023-06-30 0000828146 2023-04-01 2023-06-30 0000828146 ilink:BkfCapitalMember 2024-06-30 0000828146 ilink:BkfCapitalMember 2024-03-31 0000828146 ilink:BkfCapitalMember 2023-12-31 0000828146 ilink:BkfCapitalMember 2023-06-30 0000828146 ilink:QbakMember 2023-03-31 0000828146 ilink:BkfCapitalMember 2023-03-31 0000828146 ilink:QbakMember 2022-12-31 0000828146 ilink:BkfCapitalMember 2022-12-31 0000828146 ilink:QbakMember 2024-06-30 0000828146 ilink:QbakMember 2024-03-31 0000828146 ilink:QbakMember 2023-12-31 0000828146 2023-12-31 0000828146 ilink:QbakMember 2023-06-30 0000828146 us-gaap:ManufacturingFacilityMember 2024-06-01 2024-06-30 0000828146 us-gaap:ManufacturingFacilityMember 2024-05-01 2024-05-31 0000828146 ilink:SpaceForExecutiveOfficesSalesFinanceAndAdministrationMember ilink:SubleaseAgreementOfSpaceLocatedInIrvineCaliforniaMember 2024-03-01 2024-03-31 0000828146 ilink:SubleaseAgreementOfSpaceLocatedInIrvineCaliforniaMember 2024-01-01 2024-06-30 0000828146 country:SG 2024-01-01 2024-06-30 0000828146 country:JP 2024-01-01 2024-06-30 0000828146 country:HK 2024-01-01 2024-06-30 0000828146 ilink:SpaceForExecutiveOfficesSalesFinanceAndAdministrationMember ilink:SubleaseAgreementOfSpaceLocatedInIrvineCaliforniaMember 2023-06-01 2023-06-30 0000828146 ilink:NewarkCaliforniaManufacturingFacilityMember 2023-02-01 2023-02-28 0000828146 ilink:SpaceForExecutiveOfficesSalesFinanceAndAdministrationMember ilink:SubleaseAgreementOfSpaceLocatedInIrvineCaliforniaMember 2020-06-01 2023-05-31 0000828146 srt:ChiefExecutiveOfficerMember 2024-01-01 2024-06-30 0000828146 2024-03-01 2024-03-01 0000828146 us-gaap:ManufacturingFacilityMember 2024-06-30 0000828146 ilink:SubleaseAgreementOfSpaceLocatedInIrvineCaliforniaMember 2024-06-30 0000828146 ilink:NewarkCaliforniaManufacturingFacilityMember 2024-06-30 0000828146 country:SG 2024-06-30 0000828146 country:JP 2024-06-30 0000828146 country:HK 2024-06-30 0000828146 us-gaap:ManufacturingFacilityMember 2024-05-31 0000828146 ilink:SpaceForExecutiveOfficesSalesFinanceAndAdministrationMember ilink:SubleaseAgreementOfSpaceLocatedInIrvineCaliforniaMember 2023-06-30 0000828146 ilink:SpaceForExecutiveOfficesSalesFinanceAndAdministrationMember 2023-05-31 0000828146 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2024-01-01 2024-06-30 0000828146 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-12-31 0000828146 ilink:FremontCaliforniaFacilityMember 2024-03-01 2024-03-31 0000828146 2024-06-30 0000828146 ilink:CalmanTechnologyLimitedMember 2023-03-17 0000828146 ilink:CalmanTechnologyLimitedMember ilink:SharePurchaseAgreementMember 2023-03-17 0000828146 ilink:CalmanTechnologyLimitedMember ilink:SharePurchaseAgreementMember 2023-03-17 2023-03-17 0000828146 ilink:FremontCaliforniaFacilityMember 2024-03-31 0000828146 2023-01-01 2023-06-30 0000828146 2024-04-01 2024-06-30 0000828146 2024-08-08 0000828146 2024-01-01 2024-06-30 xbrli:shares iso4217:USD utr:sqft iso4217:GBP xbrli:pure ilink:customer iso4217:USD xbrli:shares ilink:segment

Table of Contents

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2024

or

☐ Transition Report Pursuant Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________________ to ______________________.

Commission file number 001-37659

INTERLINK ELECTRONICS, INC.

(Exact name of registrant as specified in its charter)

​ | ​ | ​
Nevada |  | 77-0056625
(State or other jurisdiction of | ​ | (I.R.S. Employer
incorporation or organization) | ​ | Identification No.)

​

15707 Rockfield Boulevard, Suite 105

Irvine, California 92618

(Address of principal executive offices, zip code)

(805) 484-8855

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

​ | ​ | ​ | ​ | ​
Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common stock, $0.001 par value per share | ​ | LINK | ​ | The Nasdaq Stock Market LLC

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

​ | ​ | ​
Large accelerated filer ☐ |  | Accelerated filer ☐
Non-accelerated filer ☒ | ​ | Smaller reporting company ☒
​ | ​ | Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of August 8, 2024, the issuer had 9,864,214 shares of common stock issued and outstanding.

​

​

​

​

Table of Contents

INTERLINK ELECTRONICS, INC.

TABLE OF CONTENTS

​

| Page No.
PART I -- FINANCIAL INFORMATION
Item 1. | Financial Statements (unaudited) | 3
​ |  |
​ | Condensed Consolidated Balance Sheets | 3
​ |  |
​ | Condensed Consolidated Statements of Operations | 4
​ |  |
​ | Condensed Consolidated Statements of Comprehensive Income (Loss) | 5
​ |  |
​ | Condensed Consolidated Statements of Stockholders’ Equity | 6
​ | ​ | ​
​ | Condensed Consolidated Statements of Cash Flows | 7
​ |  |
​ | Notes to Condensed Consolidated Financial Statements | 8
​ |  |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 23
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 29
Item 4. | Controls and Procedures | 30
PART II -- OTHER INFORMATION
Item 1A. | Risk Factors | 31
Item 5. | Other Information | 31
​ | ​ | ​
Item 6. | Exhibits | 32
Signatures | 33

​

​

​

2

Table of Contents

PART I: FINANCIAL INFORMATION

Item 1. Financial Statements

INTERLINK ELECTRONICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ |  | 2024 |  | 2023
​ |  | (in thousands, except par value)
ASSETS | ​ | ​ | ​ | ​ | ​ | ​
Current assets | ​ | ​ | ​ | ​ | ​ | ​
Cash and cash equivalents |  | $ | 3,960 |  | $ | 4,304
Accounts receivable, net | ​ | ​ | 1,477 | ​ | ​ | 2,167
Inventories | ​ | ​ | 2,555 | ​ | ​ | 2,476
Prepaid expenses and other current assets | ​ | ​ | 303 | ​ | ​ | 381
Total current assets | ​ | ​ | 8,295 | ​ | ​ | 9,328
Property, plant and equipment, net | ​ | ​ | 254 | ​ | ​ | 313
Intangible assets, net | ​ | ​ | 2,251 | ​ | ​ | 2,654
Goodwill | ​ | ​ | 2,438 | ​ | ​ | 2,461
Right-of-use assets | ​ | ​ | 814 | ​ | ​ | 143
Deferred tax assets | ​ | ​ | 86 | ​ | ​ | 83
Other assets | ​ | ​ | 103 | ​ | ​ | 80
Total assets |  | $ | 14,241 |  | $ | 15,062
​ | ​ | ​ | ​ | ​ | ​ | ​
LIABILITIES AND STOCKHOLDERS’ EQUITY | ​ | ​ | ​ | ​ | ​ | ​
Current liabilities | ​ | ​ | ​ | ​ | ​ | ​
Accounts payable |  | $ | 360 |  | $ | 464
Accrued liabilities | ​ | ​ | 429 | ​ | ​ | 492
Lease liabilities, current | ​ | ​ | 259 | ​ | ​ | 126
Accrued income taxes | ​ | ​ | 392 | ​ | ​ | 293
Total current liabilities | ​ | ​ | 1,440 | ​ | ​ | 1,375
​ | ​ | ​ | ​ | ​ | ​ | ​
Long-term liabilities | ​ | ​ | ​ | ​ | ​ | ​
Lease liabilities, long term | ​ | ​ | 592 | ​ | ​ | 33
Deferred tax liabilities | ​ | ​ | 540 | ​ | ​ | 626
Total long-term liabilities | ​ | ​ | 1,132 | ​ | ​ | 659
Total liabilities | ​ | ​ | 2,572 | ​ | ​ | 2,034
​ | ​ | ​ | ​ | ​ | ​ | ​
Commitments and contingencies (Note 9) | ​ | ​ | — | ​ | ​ | —
​ | ​ | ​ | ​ | ​ | ​ | ​
Stockholders’ equity | ​ | ​ | ​ | ​ | ​ | ​
Preferred stock, $0.01 par value: 1,000 shares authorized, 200 shares of Series A Convertible Preferred Stock issued and outstanding at both June 30, 2024 and December 31, 2023 ($5.0 million liquidation preference) | ​ | ​ | 2 | ​ | ​ | 2
Common stock, $0.001 par value: 30,000 shares authorized, 9,860 shares issued and outstanding at both June 30, 2024 and December 31, 2023 | ​ | ​ | 10 | ​ | ​ | 10
Additional paid-in-capital | ​ | ​ | 62,284 | ​ | ​ | 62,279
Accumulated other comprehensive income | ​ | ​ | 84 | ​ | ​ | 200
Accumulated deficit | ​ | ​ | (50,711) | ​ | ​ | (49,463)
Total stockholders’ equity | ​ | ​ | 11,669 | ​ | ​ | 13,028
Total liabilities and stockholders’ equity |  | $ | 14,241 |  | $ | 15,062

​

See accompanying notes to these unaudited condensed consolidated financial statements.

​

3

Table of Contents

INTERLINK ELECTRONICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
​ |  | (in thousands, except per share data) | ​ | ​ | ​ | ​ | ​ | ​
Revenue, net |  | $ | 2,898 |  | $ | 4,049 |  | $ | 6,022 |  | $ | 7,327
Cost of revenue | ​ | ​ | 1,593 | ​ | ​ | 1,988 | ​ | ​ | 3,464 | ​ | ​ | 3,679
Gross profit | ​ | ​ | 1,305 | ​ | ​ | 2,061 | ​ | ​ | 2,558 | ​ | ​ | 3,648
Operating expenses: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Engineering, research and development | ​ | ​ | 510 | ​ | ​ | 650 | ​ | ​ | 1,086 | ​ | ​ | 1,177
Selling, general and administrative | ​ | ​ | 1,108 | ​ | ​ | 1,005 | ​ | ​ | 2,536 | ​ | ​ | 2,238
Total operating expenses | ​ | ​ | 1,618 | ​ | ​ | 1,655 | ​ | ​ | 3,622 | ​ | ​ | 3,415
Income (loss) from operations | ​ | ​ | (313) | ​ | ​ | 406 | ​ | ​ | (1,064) | ​ | ​ | 233
Other income (expense), net | ​ | ​ | 16 | ​ | ​ | 64 | ​ | ​ | 48 | ​ | ​ | 128
Income (loss) before income taxes | ​ | ​ | (297) | ​ | ​ | 470 | ​ | ​ | (1,016) | ​ | ​ | 361
Income tax expense | ​ | ​ | 10 | ​ | ​ | 89 | ​ | ​ | 32 | ​ | ​ | 171
Net income (loss) | ​ | $ | (307) | ​ | $ | 381 | ​ | $ | (1,048) | ​ | $ | 190
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) applicable to common stockholders |  | $ | (407) |  | $ | 281 |  | $ | (1,248) |  | $ | (10)
Earnings (loss) per common share – basic and diluted | ​ | $ | (0.04) | ​ | $ | 0.03 | ​ | $ | (0.13) | ​ | $ | 0.00
Weighted average common shares outstanding – basic and diluted | ​ | ​ | 9,860 | ​ | ​ | 9,900 | ​ | ​ | 9,860 | ​ | ​ | 9,915

​

See accompanying notes to these unaudited condensed consolidated financial statements.

​

​

4

Table of Contents

INTERLINK ELECTRONICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, |  | Six Months Ended June 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
​ | ​ | (in thousands)
Net income (loss) | ​ | $ | (307) | ​ | $ | 381 | ​ | $ | (1,048) | ​ | $ | 190
Other comprehensive income (loss), net of tax: | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Foreign currency translation adjustments | ​ |  | (9) | ​ | ​ | 13 | ​ | ​ | (116) | ​ | ​ | 195
Comprehensive income (loss) | ​ | $ | (316) | ​ | $ | 394 | ​ | $ | (1,164) | ​ | $ | 385

​

See accompanying notes to these unaudited condensed consolidated financial statements.

​

​

5

Table of Contents

INTERLINK ELECTRONICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | ​ | ​ |  |  | ​ | ​ |  | ​ | ​ |  | Accumulated |  | ​ | ​ |  | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | Other | ​ | ​ | ​ | ​ | Total
​ | ​ | Preferred Stock | ​ | Common Stock | ​ | Paid-in- | ​ | Comprehensive | ​ | Accumulated | ​ | Stockholders’
Three months ended June 30, 2024 |  | Shares |  | Amount |  | Shares |  | Amount |  | Capital |  | Income (Loss) |  | Deficit |  | Equity
(in thousands) |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance at March 31, 2024 |  | 200 | ​ | $ | 2 | ​ | 9,860 | ​ | $ | 10 | ​ | $ | 62,279 | ​ | $ | 93 | ​ | $ | (50,304) | ​ | $ | 12,080
Net loss |  | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (307) | ​ | ​ | (307)
Stock-based compensation expense |  | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | 5 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 5
Preferred stock dividends |  | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (100) | ​ | ​ | (100)
Foreign currency translation adjustment |  | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (9) | ​ | ​ | — | ​ | ​ | (9)
Balance at June 30, 2024 |  | 200 | ​ | $ | 2 | ​ | 9,860 | ​ | $ | 10 | ​ | $ | 62,284 | ​ | $ | 84 | ​ | $ | (50,711) | ​ | $ | 11,669

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | ​ | ​ |  |  | ​ | ​ |  | ​ | ​ |  | Accumulated |  | ​ | ​ |  | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | Other | ​ | ​ | ​ | ​ | Total
​ | ​ | Preferred Stock | ​ | Common Stock | ​ | Paid-in- | ​ | Comprehensive | ​ | Accumulated | ​ | Stockholders’
Six months ended June 30, 2024 |  | Shares |  | Amount |  | Shares |  | Amount |  | Capital |  | Income (Loss) |  | Deficit |  | Equity
(in thousands) |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance at December 31, 2023 |  | 200 | ​ | $ | 2 | ​ | 9,860 | ​ | $ | 10 | ​ | $ | 62,279 | ​ | $ | 200 | ​ | $ | (49,463) | ​ | $ | 13,028
Net loss | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (1,048) | ​ | ​ | (1,048)
Stock-based compensation expense |  | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | 5 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 5
Preferred stock dividends | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (200) | ​ | ​ | (200)
Foreign currency translation adjustment |  | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (116) | ​ | ​ | — | ​ | ​ | (116)
Balance at June 30, 2024 |  | 200 | ​ | $ | 2 | ​ | 9,860 | ​ | $ | 10 | ​ | $ | 62,284 | ​ | $ | 84 | ​ | $ | (50,711) | ​ | $ | 11,669

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | ​ | ​ |  |  | ​ | ​ |  | ​ | ​ |  | Accumulated |  | ​ | ​ |  | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | Other | ​ | ​ | ​ | ​ | Total
​ | ​ | Preferred Stock | ​ | Common Stock | ​ | Paid-in- | ​ | Comprehensive | ​ | Accumulated | ​ | Stockholders’
Three months ended June 30, 2023 |  | Shares |  | Amount |  | Shares |  | Amount |  | Capital |  | Income (Loss) |  | Deficit |  | Equity
(in thousands) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance at March 31, 2023 | ​ | 200 | ​ | $ | 2 | ​ | 9,915 | ​ | $ | 10 | ​ | $ | 62,614 | ​ | $ | 84 | ​ | $ | (48,971) | ​ | $ | 13,739
Net income | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 381 | ​ | ​ | 381
Preferred stock dividends | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (100) | ​ | ​ | (100)
Foreign currency translation adjustment | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 13 | ​ | ​ | — | ​ | ​ | 13
Repurchases of common stock |  | — | ​ | ​ | — | ​ | (29) | ​ | ​ | — | ​ | ​ | (177) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (177)
Balance at June 30, 2023 | ​ | 200 | ​ | $ | 2 | ​ | 9,886 | ​ | $ | 10 | ​ | $ | 62,437 | ​ | $ | 97 | ​ | $ | (48,690) | ​ | $ | 13,856

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | ​ | ​ |  |  | ​ | ​ |  | ​ | ​ |  | Accumulated |  | ​ | ​ |  | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | Other | ​ | ​ | ​ | ​ | Total
​ | ​ | Preferred Stock | ​ | Common Stock | ​ | Paid-in- | ​ | Comprehensive | ​ | Accumulated | ​ | Stockholders’
Six months ended June 30, 2023 |  | Shares |  | Amount |  | Shares |  | Amount |  | Capital |  | Income (Loss) |  | Deficit |  | Equity
(in thousands) |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance at December 31, 2022 |  | 200 | ​ | $ | 2 | ​ | 9,915 | ​ | $ | 10 | ​ | $ | 62,614 | ​ | $ | (98) | ​ | $ | (48,680) | ​ | $ | 13,848
Net income |  | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 190 | ​ | ​ | 190
Preferred stock dividends |  | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (200) | ​ | ​ | (200)
Foreign currency translation adjustment |  | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 195 | ​ | ​ | — | ​ | ​ | 195
Repurchases of common stock | ​ | — | ​ | ​ | — | ​ | (29) | ​ | ​ | — | ​ | ​ | (177) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (177)
Balance at June 30, 2023 |  | 200 | ​ | $ | 2 | ​ | 9,886 | ​ | $ | 10 | ​ | $ | 62,437 | ​ | $ | 97 | ​ | $ | (48,690) | ​ | $ | 13,856

​

See accompanying notes to these unaudited condensed consolidated financial statements.

​

​

6

Table of Contents

INTERLINK ELECTRONICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Six months ended June 30,
​ |  | 2024 |  | 2023
​ | ​ | (in thousands)
Cash flows from operating activities: | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) |  | $ | (1,048) |  | $ | 190
Adjustments to reconcile net income (loss) to net cash (used in) operating activities: | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ | ​ | 455 | ​ | ​ | 189
Stock-based compensation expense | ​ | ​ | 5 | ​ | ​ | —
Adjustment to reconcile operating lease expense to cash paid | ​ | ​ | 21 | ​ | ​ | 5
Deferred income taxes | ​ | ​ | (86) | ​ | ​ | —
Changes in operating assets and liabilities: | ​ | ​ | ​ | ​ | ​ | ​
Accounts receivable | ​ | ​ | 684 | ​ | ​ | (273)
Inventories | ​ | ​ | (102) | ​ | ​ | (189)
Prepaid expenses and other assets | ​ | ​ | 56 | ​ | ​ | 74
Accounts payable | ​ | ​ | (125) | ​ | ​ | 85
Accrued liabilities | ​ | ​ | (38) | ​ | ​ | (198)
Accrued income taxes | ​ | ​ | 102 | ​ | ​ | (128)
Net cash (used in) operating activities | ​ | ​ | (76) | ​ | ​ | (245)
Cash flows from investing activities: | ​ | ​ | ​ | ​ | ​ | ​
Acquisition of Calman Technology Limited, net of cash acquired | ​ | ​ | — | ​ | ​ | (4,278)
Purchases of property, plant and equipment | ​ | ​ | (20) | ​ | ​ | (32)
Net cash (used in) investing activities | ​ | ​ | (20) | ​ | ​ | (4,310)
Cash flows from financing activities: | ​ | ​ | ​ | ​ | ​ | ​
Payment of dividends on preferred stock | ​ | ​ | (200) | ​ | ​ | (200)
Repurchases of common stock | ​ | ​ | — | ​ | ​ | (177)
Net cash (used in) financing activities | ​ | ​ | (200) | ​ | ​ | (377)
​ | ​ | ​ | ​ | ​ | ​ | ​
Effect of exchange rate changes on cash | ​ | ​ | (48) | ​ | ​ | (53)
Net (decrease) in cash and cash equivalents | ​ | ​ | (344) | ​ | ​ | (4,985)
Cash and cash equivalents, beginning of period | ​ | ​ | 4,304 | ​ | ​ | 10,091
Cash and cash equivalents, end of period |  | $ | 3,960 |  | $ | 5,106
​ | ​ | ​ | ​ | ​ | ​ | ​
Supplemental disclosure of cash flow information: | ​ | ​ | ​ | ​ | ​ | ​
Income taxes paid, net |  | $ | 14 |  | $ | 327
Interest paid | ​ | ​ | — | ​ | ​ | —
​ | ​ | ​ | ​ | ​ | ​ | ​
Supplemental disclosure of non-cash investing and financing activities: | ​ | ​ | ​ | ​ | ​ | ​
Lease liabilities arising from obtaining right-of-use assets | ​ | $ | 795 | ​ | $ | 55

​

See accompanying notes to these unaudited condensed consolidated financial statements.

​

​

7

Table of Contents

INTERLINK ELECTRONICS, INC.

​

Notes to Condensed Consolidated Financial Statements

(unaudited)

Note 1 – The Company and its Significant Accounting Policies

Description of Business

Interlink Electronics, Inc. (“we,” “us,” “our,” “Interlink” or the “Company”) is a global sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. We design, develop, manufacture and sell a range of force-sensing and gas-sensing technologies that incorporate our proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Our force-sensing products and solutions include sensor components, subassemblies, modules and products that support effective, efficient cursor control and novel three-dimensional user inputs. Our Human Machine Interface (“HMI”) technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical. Our membrane keypads, graphic overlays, printed electronics and industrial label products are applicable for use in a wide range of fields, from industrial automation, process control and monitoring to medical and diagnostic devices and defense systems. Our electrochemical gas-sensing technology instruments, products and solutions are deployed in industry, community, health and home settings, with uses in fields such as carbon monoxide and ozone detection and air quality monitoring.

We serve our world-wide customer base from our corporate headquarters in Irvine, California; our Global Product Development and Materials Science Center and distribution and logistics center in Camarillo, California; our printed-electronics manufacturing facilities in Shenzhen, China, and Irvine, Scotland; our advanced and proprietary production and product development facility in Silicon Valley, California; our engineering, research and development center in Singapore; our technical sales office in Japan; and our distribution and logistics center in Hong Kong. Our principal executive office is located at 15707 Rockfield Boulevard, Suite 105, Irvine, California 92618 and our telephone number is (805) 484-8855. Our website address is www.interlinkelectronics.com.

March 2024 Common Stock Dividend

On March 1, 2024, the Board of Directors declared a 50% common stock dividend with a record date of March 11, 2024, that was paid on March 22, 2024. Settlement of fractional share interests was made by issuing one full share of common stock in lieu of a fractional share. The stock dividend increased the number of issued and outstanding shares of common stock from 6,573,570 to 9,860,368. Except as otherwise noted, all references to common stock, common stock issuable upon conversion of preferred stock, and corresponding per share information throughout this Quarterly Report on Form 10-Q have been retroactively adjusted to reflect the stock dividend, which is accounted for as a stock split effected in the form of a stock dividend.

Fiscal Year

Our fiscal year is the calendar year reporting cycle beginning January 1 and ending December 31.

Basis of Presentation

The accompanying unaudited interim consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intra-entity transactions and balances have been eliminated in consolidation.

The accompanying unaudited interim consolidated financial statements for the Company and its subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in annual consolidated financial statements have been condensed or omitted in accordance with Rule 10-01 of Regulation S-X. In the opinion of management, the accompanying unaudited interim consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments and the elimination of intra-entity accounts) considered necessary for a fair presentation of all periods presented. The results of the Company’s operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes included in our Annual Report on Form 10-K, which was filed the Securities and Exchange Commission on March 25, 2024.

8

Table of Contents

Use of Estimates

The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and disclosures made in the accompanying notes to the consolidated financial statements. Management regularly evaluates estimates and assumptions related to revenue recognition, allowances for doubtful accounts, warranty reserves, inventory valuation reserves, stock-based compensation, purchased intangible asset valuations and useful lives, asset retirement obligations, and deferred income tax asset valuation allowances. These estimates and assumptions are based on current facts, historical experience and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not readily apparent from other sources. The actual results we experience may differ materially and adversely from our original estimates. To the extent there are material differences between the estimates and the actual results, our future results of operations will be affected.

Revenue Recognition

We recognize revenue in accordance with Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”), when our customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. To determine revenue recognition for arrangements that are within the scope of ASC 606, we perform the following five steps; (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations; and (v) recognize revenue when (or as) we satisfy a performance obligation. The five-step model is applied to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services transferred to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations and assess whether each promised good or service is distinct. We then recognize revenue in the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Delivery occurs when goods are shipped and title and risk of loss transfer to the customer, in accordance with the terms specified in the arrangement with the customer. Revenue recognition is deferred until the earnings process is complete.

We (i) input orders based upon receipt of a customer purchase order, (ii) confirm pricing through the customer purchase order record, (iii) validate creditworthiness through past payment history, credit agency reports and other financial data, and (iv) recognize revenue upon shipment of goods or when risk of loss and title transfer to the buyer. All customers have warranty rights, and some customers also have explicit or implicit rights of return. We establish reserves for potential customer returns or warranty repairs based on historical experience and other factors that enable us to reasonably estimate the obligation.

A portion of our product sales is made through distributors under agreements allowing for right of return. Our past history with these sell-through right of return provisions allow us to reasonably estimate the amount of inventory that could be returned pursuant to these agreements, and revenue is recognized accordingly.

Shipping and Handling Fees and Costs

Amounts billed to customers for shipping and handling fees are included in revenues. Costs incurred for shipping and handling are included in cost of revenues.

Engineering, Research and Development Costs

Engineering, research and development (“R&D”) costs are expensed when incurred. R&D expenses consist primarily of compensation expenses for employees engaged in research, design and development activities. R&D expenses also include depreciation and amortization, and overhead, including facilities expenses.

Marketing and Advertising Costs

All of the costs related to marketing and advertising our products are expensed as incurred or at the time the marketing or advertising takes place.

9

Table of Contents

Stock-Based Compensation

All stock-based payments to employees, including grants of employee stock options and employee stock purchase rights, are recognized in the financial statements based on their respective grant date (measurement date) fair values. We calculate the compensation cost of full-value awards, such as restricted stock units, based on the market value of the underlying stock at the date of the grant. We estimate the expected life of a stock award as the period of time that the award is expected to be outstanding. We are required to estimate the fair value of stock-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense ratably over the requisite service periods. We estimate the fair value of each option award as of the date of grant using the Black-Scholes option pricing model, which was developed for use in estimating the value of traded options that have no vesting restrictions and that are freely transferable. The Black-Scholes option pricing model considers, among other factors, the expected life of the award and the expected volatility of our stock price. Although the Black-Scholes option pricing model meets the accounting guidance requirements, the fair values generated by the Black-Scholes option pricing model may not be indicative of the actual fair values of our awards, as it does not consider other factors important to those stock-based payment awards, such as continued employment, periodic vesting requirements, and limited transferability.

We have elected to recognize compensation expense for all stock-based awards on a straight-line basis over the requisite service period for the entire award. The amount of compensation expense recognized through the end of each reporting period is equal to the portion of the grant-date value of the awards that have vested, or for partially vested awards, the value of the portion of the award that is ultimately expected to vest for which the requisite services have been provided. The benefits of tax deductions in excess of recognized compensation cost are reported as a financing cash flow.

Other Income (Expense)

Other income (expense) consists of interest income, foreign currency exchange gains and losses, gains and losses on marketable securities, and other non-operating gains and losses.

Income Taxes

We account for income taxes under the asset and liability method, whereby deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. We assess the likelihood that our deferred tax assets will be recovered from future taxable income and to the extent we believe that recovery is not determinable beyond a “more likely than not” standard, we establish a valuation allowance. To the extent we establish a valuation allowance or increase or decrease this allowance in a period, we include an expense or benefit within the tax provision in the statement of operations. We also utilize a “more likely than not” recognition threshold and measurement analysis for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. We recognize potential accrued interest and penalties related to unrecognized tax benefits within the consolidated statements of operations as income tax expense.

We operate within multiple tax jurisdictions and are subject to audit in these jurisdictions. Our foreign subsidiaries are subject to foreign income taxes on earnings in their respective jurisdictions. Earnings of our foreign subsidiaries are included in our U.S. federal income tax return as they are earned.

Foreign Currency Translation

The functional currency of our Chinese subsidiary is the Chinese renminbi. The functional currency of our United Kingdom subsidiaries is the British pound sterling. The functional currency for our Hong Kong and Singapore subsidiaries is the United States dollar. Assets and liabilities are translated into United States dollars at the exchange rate in effect on the balance sheet date. Revenues and expenses are translated at the average exchange rate prevailing during the respective periods.

Comprehensive Income (Loss)

Comprehensive income (loss) includes all components of comprehensive income (loss), including net income (loss) and any changes in equity during the period from transactions and other events and circumstances generated by non-owner sources.

10

Table of Contents

Segment Reporting

We operate in one reportable segment: the manufacture and sale of force/touch sensors and gas sensors.

Earnings Per Share

Basic earnings per share is computed by dividing net income (loss) applicable to common stockholders (i.e., net income (loss) adjusted for preferred stock dividends declared or accumulated) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) applicable to common stockholders by the weighted average number of diluted common shares, which includes common stock equivalents from, if applicable, and if dilutive, unexercised stock options, unvested restricted stock units, and shares issuable upon conversion of convertible preferred stock. Unexercised stock options and unvested restricted stock units are considered to be common stock equivalents if, using the treasury stock method, they are determined to be dilutive. Convertible preferred stock is considered to be common stock equivalents if, using the if-converted method, they are determined to be dilutive.

Under the two-class method of determining earnings for each class of stock, we consider the dividend rights and participating rights in undistributed earnings for each class of stock.

Leases

We account for our leases under ASC 842. Under this guidance, arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the consolidated balance sheet as both a right of use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or our incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right of use asset is amortized over the lease term. For finance leases, interest on the lease liability and the amortization of the right of use asset results in front-loaded expense over the lease term. Variable lease expenses are recorded when incurred.

In calculating the right of use and lease liability, we have elected to combine lease and non-lease components. We exclude short-term leases having an initial term of 12 months or less from the new guidance as an accounting policy election and recognize rent expense on a straight-line basis over the lease term.

Risk and Uncertainties

Our future results of operations involve a number of risks and uncertainties. Factors that could affect our business or future results and cause actual results to vary materially from historical results include, but are not limited to, the rapid change in our industry; problems with the performance, reliability or quality of our products; loss of customers; impacts of doing business internationally, including foreign currency fluctuations, changes in the trade policies of countries in which we or our customers do business, and political instability; potential shortages of the supplies we use to manufacture our products; disruptions in our manufacturing facilities; changes in environmental directives impacting our manufacturing process or product lines; the development of new proprietary technology and the enforcement of intellectual property rights by or against us; our ability to attract and retain qualified employees; and our ability to raise additional capital.

Our operations and financial results may be adversely affected by outbreaks of viruses, widespread illness, infectious diseases, contagions and unforeseen epidemics (such as the COVID-19 coronavirus) in countries in which our products are manufactured and sold. We experienced delays in the receipt of certain goods and the supply of our products from international and domestic shipping origins as a result of the COVID-19 pandemic and more general global supply chain constraints in fiscal 2021, and to a lesser extent in fiscal 2022 and 2023, and so far in fiscal 2024. Depending on the continued extent and duration of these and similar constraints and disruptions, our supply chain, results of operations (including sales) or future business may be materially and adversely impacted. These and other issues affecting our international suppliers or internationally manufactured merchandise could have a material adverse effect on our business, results of operations and financial condition.

11

Table of Contents

Fair Value Measurements

We determine fair value measurements based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, we follow the following fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) our own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs):

Level 1: Observable inputs such as quoted prices for identical assets or liabilities in active markets;

Level 2: Other inputs observable directly or indirectly, such as quoted prices for similar assets or liabilities or market-corroborate inputs; and

Level 3: Unobservable inputs for which there is little or no market data and which requires the owner of the assets or liabilities to develop its own assumptions about how market participants would price these assets or liabilities.

Our assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of assets and liabilities and their placement within the fair value hierarchy.

Recently Issued Accounting Pronouncements

We reviewed all recently issued accounting pronouncements and concluded they are not applicable or not expected to be material to our financial statements.

Subsequent Events

We have evaluated subsequent events through August 8, 2024, being the date these condensed consolidated financial statements were issued.

​

Note 2 – Details of Certain Financial Statement Components

Inventories, stated at the lower of cost or net realizable value, consisted of the following:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ |  | 2024 |  | 2023
Inventories |  | (in thousands)
Raw materials |  | $ | 2,030 |  | $ | 1,986
Work-in-process | ​ | ​ | 217 | ​ | ​ | 232
Finished goods | ​ | ​ | 308 | ​ | ​ | 258
Total inventories |  | $ | 2,555 |  | $ | 2,476

​

Property, plant and equipment, net, consisted of the following:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ |  | 2024 |  | 2023
Property, plant and equipment, net | ​ | (in thousands)
Furniture, machinery and equipment | ​ | $ | 1,852 | ​ | $ | 2,009
Leasehold improvements | ​ |  | 404 | ​ |  | 412
​ | ​ |  | 2,256 | ​ |  | 2,421
Less: accumulated depreciation | ​ |  | (2,002) | ​ |  | (2,108)
Total property, plant and equipment, net | ​ | $ | 254 | ​ | $ | 313

​

Depreciation expense totaled $37,000 and $46,000 for the three months ended June 30, 2024 and 2023, respectively. Depreciation expense totaled $77,000 and $83,000 for the six months ended June 30, 2024 and 2023, respectively.

12

Table of Contents

Intangible assets, net, consisted of the following:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Weighted | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Average | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amortization | ​ | June 30, | ​ | December 31,
​ |  | Period |  | 2024 |  | 2023
Intangible assets, net | ​ | ​ | ​ | (in thousands)
Patents, tradenames, and trademarks | ​ | 5 years | ​ | $ | 932 | ​ | $ | 935
Developed technology | ​ | 3.5 years | ​ | ​ | 539 | ​ | ​ | 543
Customer relationships | ​ | 6 years | ​ | ​ | 1,435 | ​ | ​ | 1,449
Non-compete agreements | ​ | 4 years | ​ | ​ | 921 | ​ | ​ | 930
Order backlog | ​ | 0.5 years | ​ | ​ | 22 | ​ | ​ | 22
In-process research and development | ​ | Indefinite | ​ | ​ | 29 | ​ | ​ | 29
​ | ​ | ​ | ​ | ​ | 3,878 | ​ | ​ | 3,908
Less: accumulated amortization | ​ | ​ | ​ |  | (1,627) | ​ |  | (1,254)
Total intangible assets, net | ​ | ​ | ​ | $ | 2,251 | ​ | $ | 2,654

​

Amortization expense totaled $189,000 and $94,000 for the three months ended June 30, 2024 and 2023, respectively. Amortization expense totaled $378,000 and $106,000 for the six months ended June 30, 2024 and 2023, respectively. Future amortization expense on existing intangible assets is as follows:

​

​ | ​ | ​ | ​
Years ending December 31, |  | (in thousands)
2024 (remainder of year) | ​ | $ | 373
2025 | ​ |  | 662
2026 | ​ |  | 540
2027 | ​ |  | 333
2028 | ​ |  | 261
Thereafter | ​ | ​ | 82
​ | ​ | $ | 2,251

​

The changes in the carrying amount of goodwill for the periods ended June 30, 2024 and 2023 are as follows:

​

​ | ​ | ​ | ​
​ |  | ​ | (in thousands)
Balance as of January 1, 2024 | ​ | $ | 2,461
Adjustment to goodwill, foreign currency exchange rate changes | ​ |  | (23)
Balance as of June 30, 2024 | ​ | $ | 2,438

​

​ | ​ | ​ | ​
​ |  | ​ | (in thousands)
Balance as of January 1, 2023 |  | $ | 650
Goodwill acquired in acquisition of Calman (before December 2023 adjustment to allocation) | ​ | ​ | 4,052
Adjustment to goodwill, foreign currency exchange rate changes | ​ | ​ | (157)
Balance as of June 30, 2023 |  | $ | 4,545

​

Accrued liabilities consisted of the following:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ |  | 2024 |  | 2023
Accrued liabilities | ​ | (in thousands)
Accrued wages and benefits | ​ | $ | 158 | ​ | $ | 204
Accrued vacation | ​ |  | 164 | ​ |  | 185
Other accrued liabilities | ​ |  | 107 | ​ |  | 103
Total accrued liabilities | ​ | $ | 429 | ​ | $ | 492

​

​

13

Table of Contents

Note 3 – Acquisition of Calman Technology Limited

On March 17, 2023, we acquired all of the outstanding shares in Calman Technology Limited (“Calman”), a Scotland-based designer and manufacturer of membrane keypads, graphic overlays and printed electronics, pursuant to a Share Purchase Agreement (the “Share Purchase Agreement”) by and among the Company’s wholly owned United Kingdom subsidiary, Interlink Electronics Limited, and the shareholders of Calman. The Share Purchase Agreement contains customary representations, warranties and covenants, including non-competition covenants on the part of the sellers, who continue to be employed by Calman. Under the terms of the Share Purchase Agreement, the purchase price was GB£4,127,000 (approximately $4,912,000), of which GB£3,627,000 (approximately $4,317,000) was paid at closing and the remaining GB£500,000 (approximately $595,000) was held back against potential claims for breaches of representations and warranties (subject to certain deductibles and caps) and was paid to the sellers in December 2023.The purchase price was subject to adjustment based on the extent, if any, to which Calman’s net working capital at closing was more or less than GB£600,000 (approximately $714,000), which resulted in additional purchase consideration of approximately GB£1,292,000 (approximately $1,538,000).

The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date, giving effect to the post-closing purchase price adjustment and the revised allocation based on the results of the valuation report (in thousands).

​

​ | ​ | ​ | ​
Cash |  | $ | 1,577
Accounts receivable | ​ |  | 656
Inventories | ​ |  | 622
Prepaid expenses and other current assets | ​ |  | 12
Property, plant, and equipment | ​ |  | 146
Right-of-use assets | ​ |  | 91
Accounts payable and accrued liabilities | ​ |  | (615)
Lease liabilities | ​ |  | (91)
Net identifiable tangible assets acquired | ​ | ​ | 2,398
Developed technology | ​ | ​ | 381
Tradenames and trademarks | ​ | ​ | 214
Customer relationships | ​ | ​ | 1,260
Non-compete agreements | ​ |  | 843
Deferred tax liabilities | ​ | ​ | (710)
Goodwill | ​ |  | 2,064
Net assets acquired | ​ | $ | 6,450

​

The goodwill recognized is attributable primarily to expected synergies and the assembled workforce of Calman. The goodwill is not expected to be deductible for income tax purposes.

The following represents the pro forma consolidated statement of operations as if Calman had been included in our consolidated results for the full periods ended June 30, 2024 and 2023:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Pro Forma |  | Pro Forma
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
​ | ​ | (in thousands) | ​ | ​ | ​ | ​ | ​ | ​
Revenue | ​ | $ | 2,898 | ​ | $ | 4,049 | ​ | $ | 6,022 | ​ | $ | 8,088
Net income (loss) | ​ | $ | (307) | ​ | $ | 381 | ​ | $ | (1,048) | ​ | $ | 677

​

​

14

Table of Contents

Note 4 – Earnings Per Share

Basic earnings per share is computed by dividing net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period, plus the dilutive effect of any dilutive securities.

On March 1, 2024, the Board of Directors declared a 50% common stock dividend with a record date of March 11, 2024, that was paid on March 22, 2024. The effect of this stock dividend (which is accounted for as a stock split effected in the form of a stock dividend) has been applied retroactively to weighted average common shares outstanding, earnings per share, and the conversion rate and conversion price applicable for our Series A Convertible Preferred Stock, as if the 50% common stock dividend had occurred at the beginning of the earliest period presented.

The following table sets forth the computation of basic and diluted earnings per share:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | Six Months Ended
​ | ​ | June 30, | ​ | June 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
​ | ​ | (in thousands, except per share data)
Net income (loss) |  | $ | (307) | ​ | $ | 381 | ​ | $ | (1,048) | ​ | $ | 190
Less: Preferred stock dividends | ​ | ​ | (100) | ​ | ​ | (100) | ​ | ​ | (200) | ​ | ​ | (200)
Net income (loss) applicable to common stockholders | ​ | ​ | (407) | ​ | ​ | 281 | ​ | ​ | (1,248) | ​ | ​ | (10)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Weighted average common shares outstanding – basic | ​ | ​ | 9,860 | ​ | ​ | 9,900 | ​ | ​ | 9,860 | ​ | ​ | 9,915
Dilutive potential common shares from convertible preferred stock and restricted stock units | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Weighted average common shares outstanding – diluted | ​ | ​ | 9,860 | ​ | ​ | 9,900 | ​ | ​ | 9,860 | ​ | ​ | 9,915
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings (loss) per common share, basic |  | $ | (0.04) | ​ | $ | 0.03 | ​ | $ | (0.13) | ​ | $ | 0.00
Earnings (loss) per common share, diluted | ​ | $ | (0.04) | ​ | $ | 0.03 | ​ | $ | (0.13) | ​ | $ | 0.00
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Shares issuable upon conversion of Series A Convertible Preferred Stock excluded from calculation because their effect would be anti-dilutive | ​ | ​ | 600 | ​ | ​ | 600 | ​ | ​ | 600 | ​ | ​ | 600
Shares subject to restricted stock units excluded from calculation because their effect would be anti-dilutive | ​ | ​ | 31 | ​ | ​ | — | ​ | ​ | 31 | ​ | ​ | —

​

200,000 shares of Series A Convertible Preferred Stock convertible into 600,000 shares of common stock were outstanding but were not included in the computation of diluted earnings (loss) per share because their effect would be anti-dilutive due to the net losses and/or due to the $8.33 conversion price being higher than the average market price of the common stock. 31,250 restricted stock units (relating to the same number of shares of common stock) were outstanding for the periods in 2024 but were not included in the computation of diluted earnings (loss) per share for those periods because their effect would be anti-dilutive due to the net losses.

​

15

Table of Contents

Note 5 – Stockholders’ Equity

Restricted Stock Units

In May 2024, the Compensation Committee of the Company’s Board of Directors approved the Company’s grant of 31,250 restricted stock units to certain employees under the Interlink Electronics, Inc. 2016 Omnibus Incentive Plan. A summary of the status of the Company’s nonvested restricted stock units as of and for the year-to-date period ended June 30, 2024, is as follows:

​

​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted-
​ | ​ | ​ | ​ | Average
​ | ​ | ​ | ​ | Grant-Date
​ | ​ | ​ | ​ | Fair Value
Nonvested Restricted Stock Units | ​ | Shares | ​ | (per share)
Nonvested at January 1, 2024 |  | — | ​ | $ | —
Granted |  | 31,250 | ​ |  | 4.35
Vested |  | — | ​ |  | —
Forfeited |  | — | ​ |  | —
Nonvested at June 30, 2024 |  | 31,250 | ​ | $ | 4.35

​

As of June 30, 2024, there was approximately $131,000 of total unrecognized compensation cost related to nonvested restricted stock units. That cost is expected to be recognized over a weighted-average period of 4.6 years.

Stock Repurchase Transaction

In May 2023, the Company’s Board of Directors approved the Company’s repurchase of 8,250 shares of common stock that were previously issued and sold in a private transaction to an individual in December 2022. The Company repurchased the shares for $50,050 ($6.07 per share), which is the same price at which the Company issued and sold the shares in December 2022.

Stock Repurchase Program

In May 2023, the Company’s Board of Directors approved a Stock Repurchase Program to repurchase up to 100,000 shares of the Company’s common stock. During the three and six months ended June 30, 2024, the Company did not repurchase any shares. During the three months ended June 30, 2023, the Company repurchased 20,854 shares for an aggregate purchase price of approximately $127,000. The Stock Repurchase Program expired in May 2024.

​

Note 6 – Significant Customers, Concentrations of Credit Risk, and Geographic Information

We manage and operate our business through one operating segment.

Net revenues from customers equal to or greater than 10% of total net revenues are as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30, |
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023 |
Customer A |  | 24 | % | 23 | % | 20 | % | 27 | %
Customer B |  | 16 | % | 13 | % | 15 | % | * | %
Customer C | ​ | * | % | 11 | % | * | % | * | %

* Less than 10% of total net revenues

16

Table of Contents

Net revenues by geographic area are as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
​ |  | (in thousands) | ​ | (in thousands)
United States | ​ | $ | 1,403 | ​ | $ | 1,947 | ​ | $ | 2,848 | ​ | $ | 4,100
Asia and Middle East | ​ |  | 478 | ​ | ​ | 1,128 | ​ | ​ | 1,207 | ​ | ​ | 1,954
Europe and other | ​ |  | 1,017 | ​ | ​ | 974 | ​ | ​ | 1,967 | ​ | ​ | 1,273
Revenue, net | ​ | $ | 2,898 | ​ | $ | 4,049 | ​ | $ | 6,022 | ​ | $ | 7,327

​

Revenues by geographic area are based on the country of shipment destination. The geographic location of distributors and third-party manufacturing service providers may be different from the geographic location of the purchasers and/or ultimate end users.

We provide credit only to creditworthy third parties who are subject to our credit verification procedures. Accounts receivable balances are monitored on an ongoing basis, and accounts deemed to have credit risk are fully reserved. At June 30, 2024, two customers accounted for 27% and 15% of total accounts receivable. At December 31, 2023, two customers accounted for 35% and 16% of total accounts receivable. Our allowance for doubtful accounts was $0 at both June 30, 2024 and December 31, 2023.

Our long-lived assets were geographically located as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, |  | December 31,
​ |  | 2024 |  | 2023
​ |  | (in thousands)
United States | ​ | $ | 1,165 | ​ | $ | 733
Europe | ​ | ​ | 4,391 | ​ | ​ | 4,784
Asia | ​ |  | 390 | ​ | ​ | 217
Total long-lived assets | ​ | $ | 5,946 | ​ | $ | 5,734

​

​

17

Table of Contents

Note 7 – Related Party Transactions

Qualstar Corporation (OTCMKTS:QBAK)

Qualstar Corporation (OTCMKTS:QBAK) (“Qualstar”) is a related party. Steven N. Bronson, our Chairman of the Board, President and Chief Executive Officer, is also the President, Chief Executive Officer and a director of Qualstar. Ryan J. Hoffman, our Chief Financial Officer, is also the Acting Chief Financial Officer of Qualstar. Mr. Bronson, together with BKF Capital Group, Inc. (OTCMKTS:BKFG) which he controls, has a controlling interest in both Interlink and Qualstar. We have a facilities agreement with Qualstar to allow Qualstar to use a portion of our Irvine, California office facility, for which we have agreed to split substantially all rent and lease-related costs on an apportioned basis according to the approximate relative usage levels by each entity. Qualstar also has a facilities agreement with us to allow us to use of a portion of its Camarillo, California office and warehouse facility, for which we have agreed to split substantially all rent and lease-related costs on an apportioned basis according to the approximate relative usage levels by each entity. In addition, we have various consulting agreements with Qualstar for certain of our respective employees and/or independent contractors that provide certain operational, sales, marketing, general and administrative services to the other entity. Interlink and Qualstar also agree to reimburse, or be reimbursed by, one another for expenses paid by one company on behalf of the other. Transactions with Qualstar and its subsidiaries are as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended June 30,
​ |  | 2024 | ​ | 2023
​ |  | Due from |  | Due to |  | Due from |  | Due to
​ | ​ | Qualstar | ​ | Qualstar | ​ | Qualstar | ​ | Qualstar
​ |  | (in thousands)
Balance at April 1, | ​ | $ | 13 | ​ | $ | 25 | ​ | $ | 21 | ​ | $ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Billed (or accrued) to Qualstar by Interlink | ​ |  | 104 | ​ | ​ | — | ​ | ​ | 209 | ​ | ​ | —
Paid by Qualstar to Interlink | ​ |  | (101) | ​ | ​ | — | ​ | ​ | (144) | ​ | ​ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Billed (or accrued) to Interlink by Qualstar | ​ |  | — | ​ | ​ | 37 | ​ | ​ | — | ​ | ​ | 31
Paid by Interlink to Qualstar | ​ |  | — | ​ | ​ | (51) | ​ | ​ | — | ​ | ​ | (22)
Balance at June 30, | ​ | $ | 16 | ​ | $ | 11 | ​ | $ | 86 | ​ | $ | 9

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Six months ended June 30,
​ |  | 2024 | ​ | 2023
​ |  | Due from |  | Due to |  | Due from |  | Due to
​ | ​ | Qualstar | ​ | Qualstar | ​ | Qualstar | ​ | Qualstar
​ |  | (in thousands)
Balance at January 1, | ​ | $ | 1 | ​ | $ | 32 | ​ | $ | 6 | ​ | $ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Billed (or accrued) to Qualstar by Interlink | ​ |  | 180 | ​ | ​ | — | ​ | ​ | 434 | ​ | ​ | —
Paid by Qualstar to Interlink | ​ |  | (165) | ​ | ​ | — | ​ | ​ | (354) | ​ | ​ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Billed (or accrued) to Interlink by Qualstar | ​ |  | — | ​ | ​ | 73 | ​ | ​ | — | ​ | ​ | 56
Paid by Interlink to Qualstar | ​ |  | — | ​ | ​ | (94) | ​ | ​ | — | ​ | ​ | (47)
Balance at June 30, | ​ | $ | 16 | ​ | $ | 11 | ​ | $ | 86 | ​ | $ | 9

​

18

Table of Contents

BKF Capital Group, Inc. (OTCMKTS:BKFG)

BKF Capital Group, Inc. (OTCMKTS:BKFG) (“BKF Capital”) is a related party. Steven N. Bronson, our Chairman of the Board, President and Chief Executive Officer, is also the Chief Executive Officer and Chairman of BKF Capital. Ryan J. Hoffman, our Chief Financial Officer, is also the Chief Financial Officer of BKF Capital. Mr. Bronson, together with BKF Capital, has a controlling interest in Interlink. We have a facilities agreement with BKF Capital to allow BKF Capital to use a portion of our Irvine, California office facility, for which we have agreed to split substantially all rent and lease-related costs on an apportioned basis according to the approximate relative usage levels by each entity. In addition, we have consulting agreements with BKF Capital for certain of our respective employees and/or independent contractors that provide certain operational and general and administrative services to the other entity. We entered into a M&A advisory consulting services agreement with Bronson Financial LLC (“BF”), a wholly owned subsidiary of BKF Capital, pursuant to which BF provides M&A advisory consulting services to us. This agreement was terminated in April 2024. Interlink and BKF Capital also agree to reimburse, or be reimbursed by, one another for expenses paid by one company on behalf of the other. Transactions with BKF Capital and its subsidiaries are as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended June 30,
​ | ​ | 2024 | ​ | 2023
​ |  | Due from |  | Due to |  | Due from |  | Due to
​ | ​ | BKF Capital | ​ | BKF Capital | ​ | BKF Capital | ​ | BKF Capital
​ | ​ | (in thousands)
Balance at April 1, | ​ | $ | 1 | ​ | $ | — | ​ | $ | 17 | ​ | $ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Billed (or accrued) to BKF Capital by Interlink | ​ |  | 2 | ​ | ​ | — | ​ | ​ | 10 | ​ | ​ | —
Paid by BKF Capital to Interlink | ​ |  | (2) | ​ | ​ | — | ​ | ​ | (22) | ​ | ​ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Billed (or accrued) to Interlink by BKF Capital | ​ |  | — | ​ | ​ | 19 | ​ | ​ | — | ​ | ​ | 30
Paid by Interlink to BKF Capital | ​ |  | — | ​ | ​ | (19) | ​ | ​ | — | ​ | ​ | (30)
Balance at June 30, | ​ | $ | 1 | ​ | $ | — | ​ | $ | 5 | ​ | $ | —

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Six months ended June 30,
​ | ​ | 2024 | ​ | 2023
​ |  | Due from |  | Due to |  | Due from |  | Due to
​ | ​ | BKF Capital | ​ | BKF Capital | ​ | BKF Capital | ​ | BKF Capital
​ | ​ | (in thousands)
Balance at January 1, | ​ | $ | 2 | ​ | $ | — | ​ | $ | 2 | ​ | $ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Billed (or accrued) to BKF Capital by Interlink | ​ |  | 4 | ​ | ​ | — | ​ | ​ | 33 | ​ | ​ | —
Paid by BKF Capital to Interlink | ​ |  | (5) | ​ | ​ | — | ​ | ​ | (30) | ​ | ​ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Billed (or accrued) to Interlink by BKF Capital | ​ |  | — | ​ | ​ | 75 | ​ | ​ | — | ​ | ​ | 80
Paid by Interlink to BKF Capital | ​ |  | — | ​ | ​ | (75) | ​ | ​ | — | ​ | ​ | (80)
Balance at June 30, | ​ | $ | 1 | ​ | $ | — | ​ | $ | 5 | ​ | $ | —

​

​

Note 8 – Income Taxes

Income tax expense as a percentage of pre-tax income/loss was 3.4% for the three months ended June 30, 2024 versus 18.9% for the same quarter in the prior year, and was 3.1% for the six months ended June 30, 2024 versus 47.4% for the first half of the prior year. Our income tax expense is impacted by the mix of domestic and foreign pre-tax earnings and losses, permanent differences between book income/loss and taxable income/loss, and our ability to utilize net operating loss carryovers (“NOLs”). Accordingly, our effective tax rate typically will vary from the U.S. statutory tax rate of 21% from quarter to quarter. The effective tax rates for each of the three- and six-month periods ended June 30, 2024 and 2023 were impacted by the amount of our foreign pre-tax income and the tax expense thereon while not realizing a benefit on our domestic pre-tax loss due to the valuation allowance on our domestic NOLs.

19

Table of Contents

We experienced an ownership change under IRC Section 382 in 2010. In general, a Section 382 ownership change occurs if there is a cumulative change in our ownership by “5% shareholders” (as defined in the Internal Revenue Code of 1986, as amended) that exceeds 50 percentage points over a rolling three-year period. An ownership change generally affects the rate at which NOLs and potential other deferred tax assets are permitted to offset future taxable income. Certain state jurisdictions within which we operate contain similar provisions and limitations. As of June 30, 2024, all of the remaining federal and state NOLs are subject to annual limitations due to the 2010 ownership change.

Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize the existing deferred tax assets. We analyzed our need to record a valuation allowance against our otherwise recognizable net deferred tax assets in the federal, state and foreign jurisdictions, and we determined that a valuation allowance on federal and state deferred tax assets was necessary at both June 30, 2024 and December 31, 2023, while no valuation allowance on foreign deferred tax assets was necessary at both June 30, 2024 and December 31, 2023. The amount of deferred tax assets considered realizable could be adjusted in future periods if estimates of future taxable income during the carryforward period are reduced or increased, or if objective negative evidence in the form of cumulative losses is no longer present and additional weight is given to subjective evidence such as our projections for future profitability.

The Internal Revenue Code includes a provision, referred to as Global Intangible Low-Taxed Income (“GILTI”), which provides for a 10.5% tax on certain income of controlled foreign corporations. We have elected to account for GILTI as a period cost if and when incurred, rather than recognizing deferred taxes for basis differences expected to reverse.

Of our $4.0 million of cash at June 30, 2024, $2.3 million was held by our foreign subsidiaries. If these funds are needed for our operations in the U.S. or for acquisitions, we have several methods to repatriate the funds without significant tax effects, including repayment of intercompany loans or distributions of previously taxed income. Other distributions may require us to incur U.S. or foreign taxes to repatriate these funds.

​

Note 9 – Commitments and Contingencies

Lease Agreements

We lease facilities under non-cancellable operating leases. Our current leases expire at various dates through fiscal 2029 and frequently include renewal provisions for varying periods of time, provisions for taxes, insurance and maintenance costs, and provisions for minimum rent increases. Minimum leases payments, including scheduled rent increases are recognized as rent expenses on a straight-line basis over the term of the lease.

The rate implicit in each lease is not readily determinable, and we therefore use our incremental borrowing rate to determine the present value of the lease payments. The weighted average incremental borrowing rate used to determine the initial value of right-of-use (“ROU”) assets and lease liabilities capitalized during the six months ended June 30, 2024 was 9.5%. No new ROU assets were capitalized during the six months ended June 30, 2023.

ROU assets for operating leases are periodically reduced by impairment losses. As of June 30, 2024, we have not recognized any impairment losses for our ROU assets.

We monitor for events or changes in circumstances that require a reassessment of our leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the corresponding ROU asset unless doing so would reduce the carrying amount of the ROU asset to an amount less than zero. In that case, the amount of the adjustment that would result in a negative ROU asset balance is recorded in profit or loss.

In June 2023, we entered into a lease agreement to lease 1,560 square feet of office space in Irvine, California for approximately $4,000 per month for a term commencing June 2023 and ending May 2024. In March 2024 we extended the term of this lease through May 2025 for the same approximately $4,000 per - month rental fee. Our Irvine, California office is used for executive offices, sales, finance and administration. We previously occupied a 4,351 square-foot office space in Irvine, California from June 2020 to May 2023 under a sublease agreement for approximately $6,000 per month, plus common area maintenance costs.

We lease a 14,476 square-foot manufacturing facility and administrative office in Shenzhen, China. In May 2024, we renewed this lease for the period June 2024 through May 2026 for approximately $8,000 per month. In May 2024, we also leased an additional

20

Table of Contents

7,287 square-foot manufacturing facility in Shenzhen, China for the same June 2024 through May 2026 period for approximately $3,000 per month.

We lease a 10,635 square-foot manufacturing facility and administrative offices in Newark, California. In February 2024, we renewed this lease for the period March 2024 through February 2025 for approximately $19,000 per month. In March 2024, we entered into a new lease for a 5,183 square-foot facility in Fremont, California for a five - year and three - month period commencing May 1, 2024 for $10,625 per month, escalating 3.5% annually, plus a share of common area operating expenses.

We lease an approximately 9,800 square-foot manufacturing facility and administrative offices in Irvine, Scotland for approximately $5,000 per month. This lease term ends February 2028, with an option for us to terminate the lease in February 2025.

We lease a 275 square-foot engineering and administrative office in Singapore for approximately $1,000 per month. This lease term ends June 2025.

We lease a 3,000 square-foot logistics and distribution facility in Hong Kong for approximately $2,000 per month. This lease term ends April 2025.

We lease a 500 square-foot sales office in Tokyo, Japan for approximately $1,000 per month. This lease term ends November 2024.

As of June 30, 2024, we had current and long-term lease liabilities of $259,000 and $592,000, respectively, and right-of-use assets of $814,000. As of December 31, 2023, we had current and long-term lease liabilities of $126,000 and $33,000, respectively, and right of use assets of $143,000. Future imputed interest as of June 30, 2024 totaled $177,000. The weighted average remaining lease term of our leases as of June 30, 2024 is 1.9 years.

Future minimum lease payments under non-cancellable operating leases that have remaining non-cancellable lease terms in excess of one year are as follows:

​

​ | ​ | ​ | ​
Years ending December 31, |  | (in thousands)
2024 (remainder of year) | ​ | $ | 165
2025 |  | ​ | 298
2026 |  | ​ | 191
2027 | ​ | ​ | 138
2028 | ​ | ​ | 148
Thereafter | ​ | ​ | 88
Total undiscounted future non-cancelable minimum lease payments |  | ​ | 1,028
Less: imputed interest | ​ | ​ | (177)
Present value of lease liabilities | ​ | $ | 851

​

During the three months ended June 30, 2024, we incurred approximately $156,000 in operating lease costs, of which $86,000 are included in cost of revenue and $71,000 are included in operating expenses in our condensed consolidated statements of operations. During the six months ended June 30, 2024, we incurred approximately $280,000 in operating lease costs, of which $155,000 are included in cost of revenue and $125,000 are included in operating expenses in our condensed consolidated statements of operations.

During the three months ended June 30, 2023, we incurred approximately $129,000 in operating lease costs, of which $52,000 is included in cost of revenue and $77,000 is included in operating expenses in our condensed consolidated statements of operations. During the six months ended June 30, 2023, we incurred approximately $250,000 in operating lease costs, of which $96,000 is included in cost of revenue and $154,000 is included in operating expenses in our condensed consolidated statements of operations.

Litigation

We are not party to any legal proceedings as of June 30, 2024. We are occasionally involved in legal proceedings in the ordinary course of business, including actions against us which assert or may assert claims or seek to impose fines and penalties in substantial amounts. Related legal defense costs are expensed as incurred.

21

Table of Contents

Warranties

We establish reserves for future product warranty costs that are expected to be incurred pursuant to specific warranty provisions with our customers. We generally warrant our products against defects for one year from date of shipment, with certain exceptions in which the warranty period can extend to more than one year based on contractual agreements. Our warranty reserves are established at the time of sale and updated throughout the warranty period based upon numerous factors including historical warranty return rates and expenses over various warranty periods. Historically, our warranty returns have not been material.

Intellectual Property Indemnities

We indemnify certain customers and our contract manufacturers against liability arising from third-party claims of intellectual property rights infringement related to our products. These indemnities appear in development and supply agreements with our customers as well as manufacturing service agreements with our contract manufacturers, are not limited in amount or duration and generally survive the expiration of the contract. Given that the amount of any potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, we are unable to determine the maximum amount of losses that we could incur related to such indemnifications.

Director and Officer Indemnities and Contractual Guarantees

Pursuant to our bylaws, we will indemnify our directors and executive officers to the fullest extent permitted by Nevada law, without limitation as to amount or duration, in the event of any actual or threatened lawsuit or proceeding. Certain costs incurred in connection with such indemnifications may be recovered under certain circumstances under various insurance policies. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit or proceeding has been threatened or filed, we are unable to determine the maximum amount of losses that we could incur relating to such indemnities.

We have entered into an employment agreement with Steven N. Bronson, our Chairman of the Board, President and Chief Executive Officer. This agreement contains certain severance and change in control obligations. Under the agreement, if Mr. Bronson’s employment is terminated due to his death or disability (as such terms are defined in the agreement), Mr. Bronson or his beneficiaries will be entitled to receive: (i) his base compensation to the end of the monthly pay period immediately following the date of termination; (ii) accrued bonus payments; and (iii) immediate and full vesting of all unvested equity and/or options issued by the Company. If Mr. Bronson’s employment is terminated by him for good reason (as such term is defined in the agreement), or by us without cause, then Mr. Bronson will be entitled to receive: (i) his base compensation to the date of termination; (ii) a severance payment equal to twelve months of his base compensation; (iii) any earned bonus compensation; (iv) employee benefits for twelve months following the date of termination; (v) any vested company match 401(k) or other retirement contribution; and (vi) immediate and full vesting of all unvested equity and/or options issued by the Company.

In the event of a change in control of the Company (as such term is defined in the agreement), Mr. Bronson is entitled to receive: (i) a change in control payment in an amount equal to twelve months of his base compensation, payable as of the date the change in control occurs; and (ii) immediate and full vesting of all unvested equity and/or options issued by the Company.

Guarantees and Indemnities

In the normal course of business, we are occasionally required to undertake indemnification for which we may be required to make future payments under specific circumstances. We review our exposure under such obligations no less than annually, or more frequently as required. The amount of any potential liabilities related to such obligations cannot be accurately determined until a formal claim is filed. Historically, any such amounts that become payable have not had a material negative effect on our business, financial condition or results of operations. We maintain general and product liability insurance which may provide a source of recovery to us in the event of an indemnification claim.

​

​

22

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements. These forward-looking statements speak only as of the date of this Form 10-Q and are subject to uncertainties, assumptions and business and economic risks. As such, our actual results could differ materially from those set forth in the forward-looking statements as a result of the factors set forth below in Part II, Item 1A, “Risk Factors,” and in our other reports filed with the Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward-looking statements will be achieved or occur. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Form 10-Q to conform these statements to actual results or to changes in our expectations, except as required by law.

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect.

Overview

Interlink Electronics, Inc. is a global sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. Our force/touch sensors, including our Force-Sensing Resistor (“FSR®”) technology and related technologies, and our membrane keypads, graphic overlays and printed electronics are used extensively in Human-Machine Interface (“HMI”) devices, while our gas and environmental sensors and instruments are used in environmental and air quality monitoring across a broad range of applications. We design, develop, manufacture and sell a range of technologies that incorporate our proprietary materials technology, firmware and software into a portfolio of standard products and custom solutions.

On March 1, 2024, the Board of Directors declared a 50% common stock dividend that was paid on March 22, 2024. For all years presented, all share and per share data have been retroactively adjusted for the effect of the 50% common stock dividend, which is accounted for as a stock split effected in the form of a stock dividend.

Our principal products are:

Force/Touch Sensors. We design, develop, manufacture and sell a range of force-sensing technologies that incorporate our proprietary materials technology, firmware and software into a portfolio of standard products and custom solutions. These include sensor components, subassemblies, modules and products that support effective, efficient cursor control and novel three-dimensional user inputs. Our HMI technology platforms are deployed in a wide range of markets, including consumer electronics, automotive, industrial and medical. The application of our HMI technology platforms includes vehicle entry, vehicle multi-media control interface, rugged touch controls, presence detection, collision detection, speed and torque controls, pressure mapping, biological monitoring and others. Additionally, through the Calman acquisition in March 2023, which brought us over 25 years of HMI design and manufacturing expertise as a leading provider of specialized printed electronics, we offer customized membrane keypads, graphic overlays, printed electronics and industrial label products for use in a wide range of fields, from industrial instrumentation, process control and monitoring to medical and diagnostic devices and defense systems.

Gas and Environmental Sensors. We entered the gas and environmental sensing market in 2022 through our acquisition of the business assets of SPEC Sensors, LLC (“SPEC”) and KWJ Engineering, Inc. (“KWJ”), early pioneers in miniaturized, low-cost gas and environmental sensing technologies. Following our acquisition of these operations, we now offer electrochemical gas-sensing technology products and solutions for industry, community, health and home, with uses in fields such as safety, personal wellness and air quality monitoring.

We sell our products and solutions globally to a diverse array of customers that includes Fortune Global 500 companies with the world’s most recognizable brands, as well as start-ups, design houses, original design and equipment manufacturers, and universities. Our technology has been deployed in the consumer electronics, automotive, industrial automation, medical, defense and environmental monitoring markets. Our global presence in the United States, China, United Kingdom, Hong Kong, Singapore and

23

Table of Contents

Japan allows us to broadly provide sales and engineering support services to our existing and future worldwide customers. We manufacture our products in a state-of-the-art facility in Shenzhen, China, and in our advanced and proprietary facilities in Silicon Valley, California and Irvine, Scotland. We control 100% of the manufacturing and shipping process, which enables us to respond quickly to customer product demand and design requirements.

We have invested significantly in the expansion of our technology platforms through our own internal development to ensure we continue to provide the market with leading-edge solutions that are seamless to deploy and perform flawlessly. Having previously built an R&D organization in Singapore to develop new product offerings that will meet the market’s growing demand for touch technology and smart surfaces, in 2020 we relocated a majority of our R&D and product development efforts to Camarillo, California, where we have established a Global Product Development and Materials Science Center. Combined with the advanced and proprietary facilities in Silicon Valley and Scotland that were acquired in connection with the acquisitions of SPEC and KWJ and Calman, we believe this will allow us to grow our business and be more closely aligned with current and future top-tier customers. We also plan to explore potential strategic relationships with companies and technology institutes that will support our growth initiatives.

Critical Accounting Policies and Estimates

We prepare our consolidated financial statements in accordance with generally accepted accounting principles in the United States (“GAAP”). The preparation of consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from the estimates made by our management. To the extent that there are differences between our estimates and actual results, our future financial statements presentation, financial condition, results of operations, and cash flows will be affected.

A description of our critical accounting policies that represent the more significant judgments and estimates used in the preparation of our financial statements was provided in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 25, 2024. There have been no changes to our critical accounting policies and estimates described in the Form 10-K that have had a material impact on our condensed consolidated financial statements and related notes.

Recently Issued and Adopted Accounting Pronouncements

We reviewed all recently issued accounting pronouncements and concluded they are all not applicable or not expected to be material to our financial statements.

​

24

Table of Contents

Results of Operations

The following table sets forth certain unaudited condensed consolidated statements of operations data for the periods indicated. The percentages in the table are based on net revenues.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended June 30, | ​ | Six Months Ended June 30, |
​ | ​ | 2024 | ​ | 2023 | ​ | 2024 | ​ | 2023 |
​ | ​ | $ |  | % |  | $ |  | % |  | $ |  | % |  | $ |  | % |
​ | ​ | (in thousands, except percentages) |
Revenue, net | ​ | $ | 2,898 | ​ | 100.0 | % | $ | 4,049 | ​ | 100.0 | % | $ | 6,022 | ​ | 100.0 | % | $ | 7,327 | ​ | 100.0 | %
Cost of revenue | ​ | ​ | 1,593 | ​ | 55.0 | % | ​ | 1,988 | ​ | 49.1 | % | ​ | 3,464 | ​ | 57.5 | % | ​ | 3,679 | ​ | 50.2 | %
Gross profit | ​ | ​ | 1,305 | ​ | 45.0 | % | ​ | 2,061 | ​ | 50.9 | % | ​ | 2,558 | ​ | 42.5 | % | ​ | 3,648 | ​ | 49.8 | %
Operating expenses: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Engineering, research and development | ​ | ​ | 510 | ​ | 17.6 | % | ​ | 650 | ​ | 16.1 | % | ​ | 1,086 | ​ | 18.0 | % | ​ | 1,177 | ​ | 16.1 | %
Selling, general and administrative | ​ | ​ | 1,108 | ​ | 38.2 | % | ​ | 1,005 | ​ | 24.8 | % | ​ | 2,536 | ​ | 42.1 | % | ​ | 2,238 | ​ | 30.5 | %
Total operating expenses | ​ | ​ | 1,618 | ​ | 55.8 | % | ​ | 1,655 | ​ | 40.9 | % | ​ | 3,622 | ​ | 60.1 | % | ​ | 3,415 | ​ | 46.6 | %
Income (loss) from operations | ​ | ​ | (313) | ​ | (10.8) | % | ​ | 406 | ​ | 10.0 | % | ​ | (1,064) | ​ | (17.7) | % | ​ | 233 | ​ | 3.2 | %
Other income (expense), net | ​ | ​ | 16 | ​ | 0.6 | % | ​ | 64 | ​ | 1.6 | % | ​ | 48 | ​ | 0.8 | % | ​ | 128 | ​ | 1.7 | %
Income (loss) before income taxes | ​ | ​ | (297) | ​ | (10.2) | % | ​ | 470 | ​ | 11.6 | % | ​ | (1,016) | ​ | (16.9) | % | ​ | 361 | ​ | 4.9 | %
Income tax expense | ​ | ​ | 10 | ​ | 0.3 | % | ​ | 89 | ​ | 2.2 | % | ​ | 32 | ​ | 0.5 | % | ​ | 171 | ​ | 2.3 | %
Net income (loss) | ​ | $ | (307) | ​ | (10.6) | % | $ | 381 | ​ | 9.4 | % | $ | (1,048) | ​ | (17.4) | % | $ | 190 | ​ | 2.6 | %

​

Comparison of Three Months Ended June 30, 2024 and 2023

Revenue, net, by the markets we serve is as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three months ended June 30, | ​ | ​ | ​ | ​ | ​
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ |  | % of |  | ​ |  | % of |  | ​ |  | ​ | ​
​ | ​ | Amount | ​ | Revenue | ​ | Amount | ​ | Revenue | ​ | $ Change | ​ | % Change | ​
​ | ​ | (in thousands, except percentages) | ​
Medical | ​ | $ | 1,283 | ​ | 44.3 | % | $ | 1,690 | ​ | 41.7 | % | $ | (407) | ​ | (24.1) | %
Industrial | ​ |  | 510 | ​ | 17.6 | % | ​ | 1,227 | ​ | 30.3 | % | ​ | (717) | ​ | (58.4) | %
Consumer | ​ |  | 6 | ​ | 0.2 | % | ​ | 66 | ​ | 1.6 | % | ​ | (60) | ​ | (90.9) | %
Standard | ​ |  | 1,099 | ​ | 37.9 | % | ​ | 1,066 | ​ | 26.3 | % | ​ | 33 | ​ | 3.1 | %
Revenue, net | ​ | $ | 2,898 | ​ | 100.0 | % | $ | 4,049 | ​ | 100.0 | % | $ | (1,151) | ​ | (28.4) | %

​

We sell our custom products into the medical, industrial, and consumer markets. We sell our standard products to customers in many markets through various distribution networks. The ultimate customer for our products may come from different markets that are often unknown to us at the time of sale. Each market has different product design cycles. Products with longer design cycles often have much longer product life cycles. Medical, industrial, and environmental monitoring products generally have longer design and life cycles than consumer products. We currently have products with life cycles that have exceeded 20 years and are ongoing.

Revenues were down in the three months ended June 30, 2024 as compared to the three months ended June 30, 2023 for sales to customers in the medical, industrial, and consumer markets into which we sell our custom products, while revenues for sales of our standard products were up marginally in the second quarter of 2024 compared to the prior year. Fluctuations in our revenue result from variations in the trends and timing of shipments of our products which are impacted by fluctuations in customer demand. In the second quarter of 2024, we experienced lower demand from certain of our larger force-sensor customers in the medical, industrial, and consumer markets compared to the second quarter of 2023. In all markets, the timing of orders from our customers is not always predictable and can be concentrated in varying periods to coincide with our customers’ project and building plans.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three months ended June 30, | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ |  | % of |  | ​ | ​ |  | % of |  | ​ | ​ |  | ​ | ​
​ | ​ | Amount | ​ | Revenue | ​ | Amount | ​ | Revenue | ​ | $ Change | ​ | % Change | ​
​ | ​ | (in thousands, except percentages) | ​
Gross profit | ​ | $ | 1,305 | ​ | 45.0 | % | $ | 2,061 | ​ | 50.9 | % | $ | (756) | ​ | (36.7) | %

25

Table of Contents

Our gross profit and gross margin percentage are impacted by various factors including product mix, customer mix, sales volume, and fluctuations in our cost of revenues, which are comprised of material costs, direct and indirect production labor costs, warehousing and logistics costs, facilities costs, and other costs related to production activities. Gross profit and gross margin percentage were down during the three months ended June 30, 2024 compared to the three months ended June 30, 2023 due primarily to lower revenues and also in part to changes in product and customer mix.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three months ended June 30, | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ |  | % of |  | ​ |  | % of |  | ​ | ​ |  | ​ | ​
​ | ​ | Amount | ​ | Revenue | ​ | Amount | ​ | Revenue | ​ | $ Change | ​ | % Change | ​
​ | ​ | (in thousands, except percentages) | ​
Engineering, research and development | ​ | $ | 510 | ​ | 17.6 | % | $ | 650 | ​ | 16.1 | % | $ | (140) | ​ | (21.5) | %

​

Engineering and R&D expenses consist primarily of compensation expenses for employees engaged in research, design and development activities, plus the cost of those employees’ indirect supplies and allocation of facilities expenses. Our R&D team focuses both on internal design development in order to develop our products and solutions, as well as custom design development aimed at addressing our customers’ unique design challenges. Engineering and R&D costs for the three months ended June 30, 2024 were down compared to the three months ended June 30, 2023 due to decreased engineering employee and consultant compensation costs, offset in part by increased intangible asset amortization expense.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three months ended June 30, | ​ | ​ | ​ | ​ | ​
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ |  | % of |  | ​ |  | % of |  | ​ |  | ​ | ​
​ | ​ | Amount | ​ | Revenue | ​ | Amount | ​ | Revenue | ​ | Change | ​ | % Change | ​
​ | ​ | (in thousands, except percentages) | ​
Selling, general and administrative | ​ | $ | 1,108 | ​ | 38.2 | % | $ | 1,005 | ​ | 24.8 | % | $ | 103 | ​ | 10.2 | %

​

Selling, general and administrative expenses consist primarily of compensation expenses for sales and administrative employees, legal and other professional fees, facilities expenses and communication expenses. Selling, general and administrative costs for the three months ended June 30, 2024 were up compared to the three months ended June 30, 2023 due to increased intangible asset amortization expense due to the Calman acquisition, partly offset by lower sales and administrative compensation expense on lower headcount and lower professional services expenses.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three months ended June 30, | ​ | ​ | ​ | ​ | ​ |
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | ​ | ​ | ​ |
​ | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | ​ |
​ |  | Amount |  | Revenue |  | Amount |  | Revenue |  | $ Change |  | % Change |
​ | ​ | (in thousands, except percentages) |
Other income (expense), net | ​ | $ | 16 | ​ | 0.6 | % | $ | 64 | ​ | 1.6 | % | $ | (48) | ​ | (75.0) | %

​

Other income (expense) consists of non-operating income and expenses, such as gains and losses on marketable securities, foreign currency transaction gains and losses, interest income and expense, and other non-operating income and expenses. Other income (expense) for the three months ended June 30, 2024 was comprised of $14,000 of interest income, and $2,000 of foreign currency transaction gains, while other income (expense), net for the three months ended June 30, 2023 was comprised of $31,000 of interest income, and $33,000 of foreign currency transaction gains.

Income tax expense as a percentage of pre-tax income/loss was 3.4% for the three months ended June 30, 2024 versus 18.9% for the comparable period in the prior year. Our income tax expense is impacted by the mix of domestic and foreign pre-tax earnings and losses, permanent differences between book income/loss and taxable income/loss, and our ability to utilize net operating loss carryovers (“NOLs”). Accordingly, our effective tax rate typically will vary from the U.S. statutory tax rate of 21% from quarter to quarter. The effective tax rates for both of the three-month periods ended June 30, 2024 and 2023 were impacted by the amount of our foreign pre-tax income and the tax expense thereon while not realizing a benefit on our domestic pre-tax loss due to the valuation allowance on our domestic NOLs.

Discrete tax events may cause our effective rate to fluctuate on a quarterly basis. Certain events, including, for example, acquisitions and other business changes, which are difficult to predict, may also cause our effective tax rate to fluctuate. We are subject to changing tax laws, regulations, and interpretations in multiple jurisdictions. Corporate tax reform continues to be a priority in the U.S.

26

Table of Contents

and other jurisdictions. Additional changes to the tax system in the U.S. could have significant effects, positive and negative, on our effective tax rate and on our deferred tax assets and liabilities.

​

Comparison of Six Months Ended June 30, 2024 and 2023

Revenue, net, by the markets we serve is as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Six months ended June 30, | ​ | ​ | ​ | ​ |
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | ​ | ​ |
​ | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount |  | Revenue |  | Amount |  | Revenue |  | $ Change |  | % Change |
​ | ​ | (in thousands, except percentages) |
Medical | ​ | $ | 2,463 | ​ | 40.9 | % | $ | 3,040 | ​ | 41.5 | % | $ | (577) | ​ | (19.0) | %
Industrial | ​ |  | 1,187 | ​ | 19.7 | % | ​ | 2,185 | ​ | 29.8 | % | ​ | (998) | ​ | (45.7) | %
Consumer | ​ |  | 138 | ​ | 2.3 | % | ​ | 294 | ​ | 4.0 | % | ​ | (156) | ​ | (53.1) | %
Standard | ​ |  | 2,234 | ​ | 37.1 | % | ​ | 1,808 | ​ | 24.7 | % | ​ | 426 | ​ | 23.6 | %
Revenue, net | ​ | $ | 6,022 | ​ | 100.0 | % | $ | 7,327 | ​ | 100.0 | % | $ | (1,305) | ​ | (17.8) | %

​

Revenues were down in the six months ended June 30, 2024 as compared to the six months ended June 30, 2023 for sales to customers in the medical, industrial, and consumer markets into which we sell our custom products, while revenues for sales of our standard products were up in the 2024 period compared to the prior year. Fluctuations in our revenue result from variations in the trends and timing of shipments of our products which are impacted by fluctuations in customer demand. In the first half of 2024, we experienced lower demand from certain of our larger force-sensor customers in the medical, industrial, and consumer markets compared to the first half of 2023. In all markets, the timing of orders from our customers is not always predictable and can be concentrated in varying periods to coincide with our customers’ project and building plans.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Six months ended June 30, |  |  | ​ |  |  |
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | ​ | ​ |
​ | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount |  | Revenue |  | Amount |  | Revenue |  | $ Change |  | % Change |
​ | ​ | (in thousands, except percentages) |
Gross profit | ​ | $ | 2,558 | ​ | 42.5 | % | $ | 3,648 | ​ | 49.8 | % | $ | (1,090) | ​ | (29.9) | %

​

Gross profit and gross margin percentage were down during the six months ended June 30, 2024 compared to the six months ended June 30, 2023 due primarily to lower revenues and also in part to changes in product and customer mix.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Six months ended June 30, | ​ | ​ | ​ | ​ |
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | ​ | ​ |
​ | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount |  | Revenue |  | Amount |  | Revenue |  | $ Change |  | % Change |
​ | ​ | (in thousands, except percentages) |
Engineering, research and development | ​ | $ | 1,086 | ​ | 18.0 | % | $ | 1,177 | ​ | 16.1 | % | $ | (91) | ​ | (7.7) | %

​

Engineering and R&D costs for the six months ended June 30, 2024 were down compared to the six months ended June 30, 2023 due to decreased engineering employee and consultant compensation costs, offset in part by increased intangible asset amortization expense.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Six months ended June 30, | ​ | ​ | ​ | ​ | ​ |
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | ​ | ​ | ​ |
​ | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount |  | Revenue |  | Amount |  | Revenue |  | ​ | Change |  | % Change |
​ | ​ | (in thousands, except percentages) |
Selling, general and administrative | ​ | $ | 2,536 | ​ | 42.1 | % | $ | 2,238 | ​ | 30.5 | % | $ | 298 | ​ | 13.3 | %

​

27

Table of Contents

Selling, general and administrative costs for the six months ended June 30, 2024 were up compared to the six months ended June 30, 2023 due to increased intangible asset amortization expense due to the Calman acquisition, partly offset by lower sales and administrative compensation expense on lower headcount and lower professional services expenses.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Six months ended June 30, | ​ | ​ | ​ | ​ | ​ |
​ | ​ | 2024 | ​ | 2023 | ​ | ​ | ​ | ​ | ​ |
​ | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | % of | ​ | ​ | ​ | ​ | ​ |
​ |  | Amount |  | Revenue |  | Amount |  | Revenue |  | $ Change |  | % Change |
​ | ​ | (in thousands, except percentages) |
Other income (expense), net | ​ | $ | 48 | ​ | 0.8 | % | $ | 128 | ​ | 1.7 | % | $ | (80) | ​ | (62.5) | %

​

Other income (expense) for the six months ended June 30, 2024 was comprised of $32,000 of interest income, and $16,000 of foreign currency transaction gains, while other income (expense) for the six months ended June 30, 2023 was comprised of $98,000 of interest income, and $30,000 of foreign currency transaction gains.

Income tax expense as a percentage of pre-tax income/loss was 3.1% for the six months ended June 30, 2024 versus 47.4% for the comparable period in the prior year. Our income tax expense is impacted by the mix of domestic and foreign pre-tax earnings and losses, permanent differences between book income/loss and taxable income/loss, and our ability to utilize net operating loss carryovers (“NOLs”). The effective tax rates for both of the six-month periods ended June 30, 2024 and 2023 were impacted by the amount of our foreign pre-tax income and the tax expense thereon while not realizing a benefit on our domestic pre-tax loss due to the valuation allowance on our domestic NOLs.

​

Liquidity and Capital Resources

Cash requirements for working capital and capital expenditures have been funded from cash balances on hand, cash generated from operations, and sales of equity securities. As of June 30, 2024, we had cash and cash equivalents of $4.0 million, working capital of $6.9 million and no indebtedness. Cash and cash equivalents consist of cash and money market funds. Of our $4.0 million of cash, $2.3 million was held by foreign subsidiaries. If these funds are needed for our operations in the U.S. or for acquisitions, we have several methods to repatriate without significant tax effects, including repayment of intercompany loans or distributions of previously taxed income. Other distributions may require us to incur U.S. or foreign taxes to repatriate these funds.

We have outstanding 200,000 shares of our 8.0% Series A Convertible Preferred Stock (the “Preferred Stock”) that have an aggregate liquidation preference of $5.0 million. We pay, when, as and if declared by our Board of Directors, monthly cumulative cash dividends on the Preferred Stock at an annual rate of 8.0%; this is equivalent to $0.16667 per month and $2.00 per annum per share, based on a per share liquidation preference of $25.00. Dividends on the Preferred Stock are payable monthly in arrears on the 15th day of each calendar month. Our Board of Directors has declared, and we have paid, cash dividends on the Preferred Stock each month since the Preferred Stock was issued in October 2021, and we expect that the Board will continue to declare, and we will continue to pay, such cash dividends each month while the Preferred Stock is outstanding, subject to applicable limitations under Nevada law.

We believe that our existing cash and cash equivalents balance will be sufficient to maintain our current operations considering our current financial condition, obligations, and other expected cash flows. If our circumstances change, however, we may require additional cash. If we require additional cash, we may attempt to raise additional capital through equity, equity-linked or debt financing arrangements. If we raise additional funds by issuing equity or equity-linked securities, the ownership of our existing stockholders will be diluted. If we raise additional financing by the incurrence of indebtedness, we could be subject to fixed payment obligations and could also be subject to restrictive covenants, such as limitations on our ability to incur additional debt, and other operating restrictions that could adversely impact our ability to conduct our business. If we are unable to raise additional needed funds, we may also take measures to reduce expenses to offset any shortfall.

28

Table of Contents

Cash Flow Analysis

Our cash flows from operating, investing and financing activities are summarized as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Six Months Ended
​ | ​ | June 30,
​ | ​ | 2024 |  | 2023
​ | ​ | (in thousands)
Net cash (used in) operating activities | ​ | $ | (76) | ​ | $ | (245)
Net cash (used in) investing activities | ​ |  | (20) | ​ | ​ | (4,310)
Net cash (used in) financing activities | ​ |  | (200) | ​ | ​ | (377)

​

Net Cash (Used In) Operating Activities

For the six months ended June 30, 2024, the $76,000 of cash used in operating activities was attributable to net loss of $1,048,000, adjusted for non-cash charges of $395,000 and cash provided by changes in operating assets and liabilities of $577,000. For the six months ended June 30, 2023, the $245,000 of cash used in operating activities was attributable to net income of $190,000, adjusted for non-cash charges of $194,000 and offset by cash used in changes in operating assets and liabilities of $629,000

Accounts receivable decreased from $2.2 million at December 31, 2023 to $1.5 million at June 30, 2024 due to lower shipments during the second quarter of 2024 compared to the fourth quarter of 2023. Many of our customers pay promptly and the accounts receivable balance is generally related to the most recent shipments. Inventories increased slightly from $2.5 million at December 31, 2023 to $2.6 million at June 30, 2024. Inventory balances fluctuate depending on the timing of materials purchases and product shipments. Prepaid expenses and other current assets decreased from $381,000 at December 31, 2023 to $303,000 at June 30, 2024 due primarily to the timing of making prepayments versus when the benefits of those prepayments are consumed. Accounts payable, accrued liabilities, and accrued income taxes were unchanged from December 31, 2023 to June 30, 2024 at $1.2 million; the balances of these working capital liabilities fluctuate due to the timing of purchases and payments on inventories and other accruals of employee compensation and outside services.

Net Cash (Used In) Investing Activities

Net cash used in investing activities for the six months ended June 30, 2024 consisted of $20,000 of purchases of property, plant, and equipment. Net cash used in investing activities of $4.3 million for the six months ended June 30, 2023 consisted of $4.3 million used to acquire the equity interests of Calman (which is net of $1.6 million of cash acquired), and $32,000 of purchases of property, plant, and equipment.

Net Cash (Used In) Financing Activities

Net cash used in financing activities of $200,000 for the six months ended June 30, 2024 consisted of payment of dividends on our Preferred Stock. Net cash used in financing activities of $377,000 for the six months ended June 30, 2023 consisted of $177,000 used for repurchases of 29,104 shares of common stock and $200,000 used for payments of dividends on our Preferred Stock.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

​

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not Applicable.

​

29

Table of Contents

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The phrase “disclosure controls and procedures” refers to controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended, or the Exchange Act, such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission, or SEC. Disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to our management, including our chief executive officer, or CEO, and chief financial officer, or CFO, as appropriate to allow timely decision regarding required disclosure.

Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of June 30, 2024, the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our CEO and CFO had concluded that as of June 30, 2024, our disclosure controls and procedures were designed at a reasonable assurance level and were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Controls over Financial Reporting

There was no change in our internal control over financial reporting during the quarter ended June 30, 2024 that materially affected, or is reasonable likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

The Company’s internal control over financial reporting includes policies and procedures that (1) pertain to maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Our management, including our CEO and CFO, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. In addition, the design of any system of controls is based in part on certain assumptions about the likelihood of future events, and controls may become inadequate if conditions change. There can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

​

​

30

Table of Contents

PART II: OTHER INFORMATION

Item 1A. Risk Factors

This Quarterly Report on Form 10-Q contains forward-looking statements, which are subject to a variety of risks and uncertainties. Other actual results could differ materially from those anticipated in those forward-looking statements as a result of various factors, including those set forth in the risk factors relating to our business and common stock contained in Item 1A of our Annual Report on Form 10-K filed with the SEC on March 25, 2024. There have been no material changes to such risk factors during the six months ended June 30, 2024.

​

Item 5. Other Information

Insider Trading Arrangements

N o n e.

​

​

31

Table of Contents

Item 6. Exhibits

Exhibit |  |  |  | Incorporated by Reference |  | Filed
Number |  | Exhibit Description |  | Form |  | File Number |  | Exhibit |  | Filing Date |  | Herewith
3.1 |  | Articles of Incorporation of the Registrant |  | 10 |  | 000-21858 |  | 3.1 |  | February 17, 2016 |  |
3.2 | ​ | Certificate of Designations of Series A Preferred Stock | ​ | 8-K | ​ | 001-37659 | ​ | 3.1 | ​ | October 25, 2021 | ​ | ​
3.2.1 | ​ | Certificate of Amendment of Certificate of Designations of Series A preferred Stock | ​ | 8.K | ​ | 001-37659 | ​ | 3.1 | ​ | November 23, 2021 | ​ | ​
3.3 |  | Bylaws of the Registrant |  | 10 |  | 000-21858 |  | 3.2 |  | February 17, 2016 |  |
3.4 |  | Amendment to Bylaws of the Registrant |  | 10 |  | 000-21858 |  | 3.3 |  | February 17, 2016 |  |
4.1 | ​ | Form of the Registrant’s common stock certificate | ​ | 10 | ​ | 000-21858 | ​ | 4.1 | ​ | February 17, 2016 | ​ | ​
31.1 |  | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  |  |  |  |  |  |  | X
31.2 |  | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  |  |  |  |  |  |  | X
32.1* |  | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  |  |  |  |  |  |  |  |  | X
101.INS |  | XBRL Instance Document |  |  |  |  |  |  |  |  |  | X
101.SCH |  | XBRL Taxonomy Extension Schema Document |  |  |  |  |  |  |  |  |  | X
101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  |  |  |  |  |  |  | X
101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document |  |  |  |  |  |  |  |  |  | X
101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document |  |  |  |  |  |  |  |  |  | X
101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  |  |  |  |  |  |  | X
104 | ​ | The cover page from Interlink Electronics, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language) and contained in Exhibit 101. | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X

*The information in this exhibit is furnished and deemed not filed with the Securities and Exchange Commission for purposes of section 18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of Interlink Electronics, Inc. under the Securities Act of 1933, as amended, or the Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

​

32

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

​

Date: August 8, 2024 |  | Interlink Electronics, Inc.
​ | ​ | (Registrant)
​ | ​ | ​
​ | ​ | By: | /s/ Ryan J. Hoffman
​ | ​ |  | Ryan J. Hoffman
​ | ​ |  | Chief Financial Officer
​ | ​ |  | (Principal Financial and Accounting Officer)

​

​

33